Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Endocrine 1Breast 1

Conditions

Breast Neoplasms 2232Neoplasms 2038Lung Neoplasms 1096Colorectal Neoplasms 1036Prostatic Neoplasms 894Carcinoma, Non-Small-Cell Lung 752Carcinoma, Hepatocellular 673Stomach Neoplasms 607Pancreatic Neoplasms 602Head and Neck Neoplasms 434Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 346Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 293Urinary Bladder Neoplasms 290Leukemia, Myeloid, Acute 278Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 252Disease 244Recurrence 225Glioma 218Carcinoma, Renal Cell 207

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × Diabetes Insipidus × Clear all
NCT01465672 2014-05-20

Copeptin as a Diagnostic Marker in the Management of Neurosurgical Patients With Disturbance of Water Homeostasis

University Hospital, Basel, Switzerland

Completed
125 enrolled
Endocrine

Diabetes Insipidus, Inappropriate ADH Syndrome, Pituitary Neoplasms

NCT00390962 2008-09-23

The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)

University Hospital, Basel, Switzerland

Completed
469 enrolled
Breast

Hemorrhagic Stroke, Carcinoma, Intraductal, Noninfiltrating, Ischemic Attack, Transient, Diabetes Insipidus, Inappropriate ADH Syndrome, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡